Brief: Prosomnus® Announces FDA 510(K) Clearance For Sleep Device
02/11/2022 13:01
Nov 2 (Reuters) - Lakeshore Acquisition I Corp LAAA.O :
* PROSOMNUS® ANNOUNCES FDA 510(K) CLEARANCE FOR PROSOMNUS
EVO™
PH SLEEP AND SNORE DEVICE
Source text for Eikon: ID:nGNX2K9byC
Further company coverage: LAAA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ProSomnus
See all newsBrief: Prosomnus Sleep Technologies Says Co Enters Into Voluntary Chapter 11 Restructuring Process Which Will Take Company Private, Reduce Debt
Prosomnus Inc expected to post a loss of 31 cents a share - Earnings Preview
Prosomnus Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Prosomnus Raises $10 Million To Fuel Growth And Optimize Operations
Brief: Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy With Prosomnus Devices Is Non-Inferior To Cpap Therapy For The Treatment Of Moderate To Severe Obstructive Sleep Apnea